Completed
A Phase I/II Trial of Vaccine Therapy of HIV-1 Infected Individuals With 50-500 CD4 Cells/mm3
NCT00000755
- Conditions
- AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +14 more
- Locations
-
- UCLA CARE Center CRS Los Angeles, California, United States
- Stanford CRS Palo Alto, California, United States
- Ucsf Aids Crs San Francisco, California, United States
- University of Colorado Hospital CRS Aurora, Colorado, United States